Salud23/09/2026@HealthDesk
DePuy Synthes se separa de Johnson & Johnson
325 Paramount Drive, Raynham, Massachusetts 02767, United StatesJohnson & Johnson…
Empieza el 01/07/2027ESTIMADO 71% DE CONFIANZAdentro de 281 díasEl 10-Q de J&J correspondiente al trimestre cerrado el 28 de junio de 2026 fija como objetivo la "finalización en un plazo de 18 a 24 meses tras el anuncio inicial" del 14 de octubre de 2025 (de mediados de abril a mediados de octubre de 2027), y el director financiero Joseph Wolk dijo en julio que J&J "avanza según lo previsto hacia una separación a mediados de 2027" (Bloomberg); "mediados de 2027" se interpreta como la mitad del año, el 1 de julio de 2027, que cae dentro de esa ventana.^[1]
El negocio de ortopedia de Johnson & Johnson saldrá del grupo como DePuy Synthes —mediante una escisión libre de impuestos o mediante una venta, con Apollo en conversaciones por unos 20.000 millones de dólares— y J&J afirma que la separación va camino de completarse a mediados de 2027.
0.83
Empresas23/09/2026@HealthDesk
Apollo in Talks to Buy J&J's DePuy Synthes for About $20 Billion
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
Empieza el 11/09/2026CONFIRMADO 82% DE CONFIANZAhace 12 díasThe disclosure is Bloomberg's report, dated "September 11, 2026" (Yahoo's^[1][2][5] syndicated copy went up at 22:26 UTC and quotes Friday's closing share prices); Reuters' write-up the same evening says "Bloomberg News reported on Friday", and Quartz's 14 September story is a follow-up, so the pin is the all-day 11 September.
Bloomberg reported that Apollo Global Management is in talks to buy DePuy Synthes, J&J's $9.3 billion-a-year orthopaedics unit, at a value close to $20 billion, with a deal possible within weeks though J&J could still spin the unit off instead.
$20B
0.76
Empresas23/09/2026@HealthDesk
J&J Completes Its $1 Billion Acquisition of Firefly Bio
South San Francisco, San Mateo County, California, United StatesJohnson & Johnson…
Empieza el 29/07/2026CONFIRMADO 87% DE CONFIANZAhace 56 días"NEW BRUNSWICK, NJ (July 29, 2026) - Johnson & Johnson (NYSE: JNJ^[1][3]) today announced the successful completion of its acquisition of Firefly Bio, Inc. ... for $1 billion in cash"; the 8-K furnishing it gives "Date of report (Date of earliest event reported): July 29, 2026".
Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.
$1B
0.66
Salud23/09/2026@HealthDesk
J&J Picks Wilson, North Carolina for a Second 500-Job Drug Plant
Wilson, Wilson County, North Carolina, United StatesJohnson & Johnson…
Empieza el 09/01/2026CONFIRMADO 87% DE CONFIANZAhace 257 díasThe governor's release is dated "Friday, January 9, 2026" and begins "Today Governor Josh Stein announced Johnson & Johnson ... will expand its presence in North Carolina"; the Wilson Times^[3] says Stein "made the announcement Friday afternoon".
North Carolina Governor Josh Stein announced that Johnson & Johnson will build a second multibillion-dollar plant in Wilson, a drug product manufacturing facility for cancer and neurology medicines expected to create up to 500 jobs, beside the $2 billion biologics campus it is already building there.
0.63
Finanzas23/09/2026@HealthDesk
J&J Third-Quarter 2026 Results and Investor Call
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
Empieza el 13/10/2026 12:30PROGRAMADO 73% DE CONFIANZAdentro de 20 díasScheduled by J&J's 31 August release: it "will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 13th to review third-quarter results" and "The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call"; 8:30 a.m. EDT is 12:30 UTC.^[1]
Johnson & Johnson releases its third-quarter 2026 results at about 6:45 a.m. Eastern on Tuesday 13 October and reviews them on an 8:30 a.m. investor call hosted by CEO Joaquin Duato and CFO Joseph Wolk.
0.62
Derecho23/09/2026@HealthDesk
J&J Proposes $5.5 Billion Deal to Settle 76,000 Ovarian Cancer Talc Claims
Johnson & Johnson…Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United States
Empieza el 27/07/2026 22:15CONFIRMADO 82% DE CONFIANZAhace 58 díasJ&J's release is datelined "New Brunswick, N.J. - JULY 27, 2026 - Johnson & Johnson (NYSE: JNJ^[1]) ... today announced", and the copy filed as Exhibit 99.1 to its 8-K is marked "FOR RELEASE AT 6:15PM ET", 22:15 UTC in EDT.
Johnson & Johnson announced a proposed resolution of its remaining ovarian talc litigation, about 76,000 claims, with a $5.5 billion commitment paid per claim - no more than $3 billion in 2027 and nothing more before 2028 - if at least 95% of claimants take part.
$5.5B
0.60
Finanzas23/09/2026@HealthDesk
J&J Q2 2026 Results: $25.3B Sales, 2026 Outlook Raised
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
Empieza el 15/07/2026 12:30CONFIRMADO 83% DE CONFIANZAhace 70 díasConfirmed by J&J's release dated "New Brunswick, N.J. (July 15, 2026)", which says it "will conduct a conference call with investors to discuss this earnings release today at 8:30 a.m., Eastern Time" (12:30 UTC; the edited transcript is stamped "JULY 15, 2026 / 12:30PM GMT").^[1]
Johnson & Johnson reported second-quarter sales of $25.3 billion, up 6.6%, and adjusted EPS of $2.90, and raised its 2026 outlook to about $101.1 billion in sales and $11.68 adjusted EPS at the midpoint.
0.60
Semiconductores23/09/2026@TechDesk
TSMC's Second Kumamoto Fab (JASM) Starts 3nm Volume Production
TSMC…JASM, Haramizu, Kikuyo, Kikuchi County, Kumamoto Prefecture 869-1103, Japan
Empieza el 31/12/2028ESTIMADO12 meses de retraso71% DE CONFIANZAdentro de 2,3 añosOnly a year is given: Taiwan's MOEA says the fab is "scheduled to start installing equipment and come online in 2028", and C.C. Wei said on the 16 April 2026 call that "commercial production is scheduled to begin in 2028" - so the year's last day, estimated.^[1]
JASM's second fab in Kikuyo, Kumamoto - switched from 6nm-class chips to TSMC's 3nm process - is due to start volume production in 2028 at 15,000 12-inch wafers a month, making Japan's first 3nm chips about a year after the end-2027 start TSMC first promised.
$17B
0.60
Salud23/09/2026@HealthDesk
J&J Signs a Drug-Pricing Deal With Trump and Joins TrumpRx
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
Empieza el 08/01/2026CONFIRMADO 86% DE CONFIANZAhace 258 díasJ&J's release is datelined "New Brunswick, N.J. – JANUARY 8, 2026" and says the company "today announced a voluntary agreement with the Trump Administration"; coverage followed on 9 January.^[1]
Johnson & Johnson signed a voluntary most-favored-nation drug-pricing agreement with the Trump administration, selling medicines through TrumpRx.gov and to Medicaid at prices comparable to other developed countries in exchange for an exemption from pharmaceutical tariffs, and announced two new US plants in Pennsylvania and North Carolina.
0.60
Audio14/09/2026@GameDesk
JBL Cove Series
Stamford, Connecticut, USAJBL
Empieza el 08/10/2026CONFIRMADO 80% DE CONFIANZAdentro de 15 díasLa propia nota de prensa de JBL (https://news.jbl.com^[3]/en-CEU/269714-jbl-launches-jbl-cove-a-new-whole-home-audio-system-to-enjoy-superior-sound-throughout-the-entire-home/) anuncia la gama Cove el 1 de septiembre de 2026 e indica que los altavoces «se lanzan en blanco y negro en JBL.com^[1] a partir del 8 de octubre de 2026». Esa fecha de disponibilidad indicada por el fabricante se usa como fecha del pin.
Tres altavoces inalámbricos multisala construidos sobre la plataforma propia de JBL.
0.59
Energía23/09/2026@EnergyDesk
B&W and Denham Capital Partner to Repower Coal Plants for Data Centers
Babcock & Wilcox…1200, East Market Street, East End, Goodyear Heights, Akron, Summit County, Ohio, 44305, United States
Empieza el 10/09/2025 10:30CONFIRMADO 89% DE CONFIANZAel año pasadoStated as done, per B&W's release "(AKRON, Ohio – September 10, 2025)": "announced today the signing of a strategic partnership agreement with Denham Capital's^[4] Sustainable Infrastructure arm"; the Business Wire copy on Yahoo Finance is timestamped 2025-09-10T10:30:00Z (6:30 a.m. ET).
Babcock & Wilcox and Denham Capital's Sustainable Infrastructure arm will jointly convert existing coal-fired plants, largely to natural gas, to power data centres in the US and Europe. B&W supplies the engineering and technology; Denham leads development and financing. No plant is named yet, so the pin sits at B&W's Akron headquarters.
0.59
Semiconductores23/09/2026@TechDesk
TSMC's Dresden Fab (ESMC) Starts Production
TSMC…European Semiconductor Manufacturing Company (ESMC) GmbH, Robert-Bosch-Ring, Hellerau/Wilschdorf, 01109 Dresden, Saxony, Germany
Empieza el 31/12/2027ESTIMADO 73% DE CONFIANZAdentro de 1,3 añosTSMC's^[1][6] founding release gives a bound, not a day: "production targeted to begin by the end of 2027"; at the September 2026 topping-out the partners still said production starts in 2027 and Hardwareluxx^[3] reported tool installation "bis Ende 2027", after which the first chips follow - so 31 December 2027, estimated.
ESMC, TSMC's EUR 10 billion joint venture with Bosch, Infineon and NXP, is due to start production at its Dresden fab by the end of 2027 - Europe's first FinFET-capable foundry, making 28/22nm and 16/12nm chips mainly for cars and industry.
€10B
0.59

The release is datelined "NEW BRUNSWICK, NJ, October 14, 2025 - Johnson & Johnson ... today announced the Company's intent to separate its Orthopaedics business"; it states no time of day (CNBC's^[3] report was up at 6:29 a.m. EDT and J&J's X post at 6:40 a.m. EDT), so the pin is the all-day 14 October.

Inicio: 14 oct 202590% DE CONFIANZAsegún la fuente

J&J Announces Plan to Spin Off DePuy Synthes

Johnson & Johnson said it would separate its roughly $9.2 billion-a-year orthopaedics business into a standalone company called DePuy Synthes within 18 to 24 months, and named former Smith & Nephew chief Namal Nawana to run it.

On 14 October 2025 Johnson & Johnson announced its intent to separate its Orthopaedics business into a standalone company operating as DePuy Synthes, which it called the largest, most comprehensive orthopaedics-focused company in the world^[1][2].
J&J said it would explore multiple paths to the separation and targeted completion within 18 to 24 months, subject to works-council consultations, final board approval and regulatory approvals, with no assurance on timing or structure^[1].
The orthopaedics business - hip, knee and shoulder implants, trauma, spine and sports medicine - made about $9.2 billion in sales in fiscal 2024, roughly 10% of J&J's revenue, and serves about seven million patients a year in a $50 billion-plus market^[1][3].
Namal Nawana, a former CEO of Smith & Nephew and Alere who once ran J&J's DePuy Synthes Spine business, was named Worldwide President of DePuy Synthes with immediate effect, to lead it through and after the separation^[1][4].
J&J keeps six growth areas - Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision - and MedTech chief Tim Schmid called the move "all about shrinking to grow faster for medtech"^[1][4].
CFO Joe Wolk said the primary focus was a tax-free spinoff but J&J was open to other options and expected no material update until mid-2026; the shares fell 1.8% on the day, which also brought Q3 2025 results and a raised 2025 sales forecast^[3].
It is J&J's second big separation in two years after the 2023 spinoff of its consumer health unit as Kenvue; Citi and Goldman Sachs advised and Freshfields was legal counsel^[1][3].

@HealthDesk

Referencias 490% DE CONFIANZA

La primera entrada es siempre la fuente del pin. La confianza global es una media ponderada de la firmeza con la que cada referencia respalda las horas de inicio y fin usadas arriba; una referencia cuenta la mitad por cada 180 días que sea más antigua que la más reciente.

[1]90%
jnj.com/media-center/press-releases/johnson-johnson-announces-intent-to-separate-its-orthopaedics-business
jnj.com· Publicado el 23 sept 2026· Empieza 14 oct 2025 ✓· 56% de la puntuación
The release is datelined "NEW BRUNSWICK, NJ, October 14, 2025 - Johnson & Johnson ... today announced the Company's intent to separate its Orthopaedics business"; it states no time of day (CNBC's^[3] report was up at 6:29 a.m. EDT and J&J's X post at 6:40 a.m. EDT), so the pin is the all-day 14 October.
[2]95%
Johnson & Johnson announces intent to separate its Orthopaedics business (Form 8-K Exhibit 99.3)
sec.gov· Publicado el 14 oct 2025· 15% de la puntuación
J&J's own release as filed with the SEC on 14 October 2025 (accepted 7:22 a.m. EDT) alongside its Q3 results: same text and dateline as the source^[1].
[3]88%
J&J to spin off orthopedics business, sees 2026 sales growth of over 5%
cnbc.com· Publicado el 14 oct 2025· 15% de la puntuación
CNBC, published 6:29 a.m. EDT on 14 October 2025: reports the 18-to-24-month separation plan, the ~$9.2B unit's 10% share of revenue, Wolk's tax-free-spinoff focus and the 1.8% share drop.
[4]85%
J&J plans to spin out orthopedics business
medtechdive.com· Publicado el 14 oct 2025· 15% de la puntuación
MedTech Dive trade coverage the same day, with earnings-call quotes from Duato, Schmid and Wolk and the unit's 2025 sales trend.

Sugerir una corrección

¿Falta algo o hay un error? Dilo con tus palabras: un enlace que respalde este pin, otra fecha de inicio o fin y por qué, o un dato que falta o está mal. La IA lo contrasta con las fuentes del pin, busca otras mejores y añade cualquier página que te dé la razón. Las fuentes del propio pin siguen contando más.

Comentarios

Hilo

Responder a este pin

Salud23/09/2026@HealthDesk
DePuy Synthes se separa de Johnson & Johnson
325 Paramount Drive, Raynham, Massachusetts 02767, United StatesJohnson & Johnson…
Empieza el 01/07/2027ESTIMADO 71% DE CONFIANZAdentro de 281 díasEl 10-Q de J&J correspondiente al trimestre cerrado el 28 de junio de 2026 fija como objetivo la "finalización en un plazo de 18 a 24 meses tras el anuncio inicial" del 14 de octubre de 2025 (de mediados de abril a mediados de octubre de 2027), y el director financiero Joseph Wolk dijo en julio que J&J "avanza según lo previsto hacia una separación a mediados de 2027" (Bloomberg); "mediados de 2027" se interpreta como la mitad del año, el 1 de julio de 2027, que cae dentro de esa ventana.^[1]
El negocio de ortopedia de Johnson & Johnson saldrá del grupo como DePuy Synthes —mediante una escisión libre de impuestos o mediante una venta, con Apollo en conversaciones por unos 20.000 millones de dólares— y J&J afirma que la separación va camino de completarse a mediados de 2027.
0.83
Empresas23/09/2026@HealthDesk
Apollo in Talks to Buy J&J's DePuy Synthes for About $20 Billion
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
Empieza el 11/09/2026CONFIRMADO 82% DE CONFIANZAhace 12 díasThe disclosure is Bloomberg's report, dated "September 11, 2026" (Yahoo's^[1][2][5] syndicated copy went up at 22:26 UTC and quotes Friday's closing share prices); Reuters' write-up the same evening says "Bloomberg News reported on Friday", and Quartz's 14 September story is a follow-up, so the pin is the all-day 11 September.
Bloomberg reported that Apollo Global Management is in talks to buy DePuy Synthes, J&J's $9.3 billion-a-year orthopaedics unit, at a value close to $20 billion, with a deal possible within weeks though J&J could still spin the unit off instead.
$20B
0.76
Empresas23/09/2026@HealthDesk
J&J Completes Its $1 Billion Acquisition of Firefly Bio
South San Francisco, San Mateo County, California, United StatesJohnson & Johnson…
Empieza el 29/07/2026CONFIRMADO 87% DE CONFIANZAhace 56 días"NEW BRUNSWICK, NJ (July 29, 2026) - Johnson & Johnson (NYSE: JNJ^[1][3]) today announced the successful completion of its acquisition of Firefly Bio, Inc. ... for $1 billion in cash"; the 8-K furnishing it gives "Date of report (Date of earliest event reported): July 29, 2026".
Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.
$1B
0.66
Salud23/09/2026@HealthDesk
J&J Picks Wilson, North Carolina for a Second 500-Job Drug Plant
Wilson, Wilson County, North Carolina, United StatesJohnson & Johnson…
Empieza el 09/01/2026CONFIRMADO 87% DE CONFIANZAhace 257 díasThe governor's release is dated "Friday, January 9, 2026" and begins "Today Governor Josh Stein announced Johnson & Johnson ... will expand its presence in North Carolina"; the Wilson Times^[3] says Stein "made the announcement Friday afternoon".
North Carolina Governor Josh Stein announced that Johnson & Johnson will build a second multibillion-dollar plant in Wilson, a drug product manufacturing facility for cancer and neurology medicines expected to create up to 500 jobs, beside the $2 billion biologics campus it is already building there.
0.63
Finanzas23/09/2026@HealthDesk
J&J Third-Quarter 2026 Results and Investor Call
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
Empieza el 13/10/2026 12:30PROGRAMADO 73% DE CONFIANZAdentro de 20 díasScheduled by J&J's 31 August release: it "will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 13th to review third-quarter results" and "The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call"; 8:30 a.m. EDT is 12:30 UTC.^[1]
Johnson & Johnson releases its third-quarter 2026 results at about 6:45 a.m. Eastern on Tuesday 13 October and reviews them on an 8:30 a.m. investor call hosted by CEO Joaquin Duato and CFO Joseph Wolk.
0.62
Derecho23/09/2026@HealthDesk
J&J Proposes $5.5 Billion Deal to Settle 76,000 Ovarian Cancer Talc Claims
Johnson & Johnson…Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United States
Empieza el 27/07/2026 22:15CONFIRMADO 82% DE CONFIANZAhace 58 díasJ&J's release is datelined "New Brunswick, N.J. - JULY 27, 2026 - Johnson & Johnson (NYSE: JNJ^[1]) ... today announced", and the copy filed as Exhibit 99.1 to its 8-K is marked "FOR RELEASE AT 6:15PM ET", 22:15 UTC in EDT.
Johnson & Johnson announced a proposed resolution of its remaining ovarian talc litigation, about 76,000 claims, with a $5.5 billion commitment paid per claim - no more than $3 billion in 2027 and nothing more before 2028 - if at least 95% of claimants take part.
$5.5B
0.60
Finanzas23/09/2026@HealthDesk
J&J Q2 2026 Results: $25.3B Sales, 2026 Outlook Raised
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
Empieza el 15/07/2026 12:30CONFIRMADO 83% DE CONFIANZAhace 70 díasConfirmed by J&J's release dated "New Brunswick, N.J. (July 15, 2026)", which says it "will conduct a conference call with investors to discuss this earnings release today at 8:30 a.m., Eastern Time" (12:30 UTC; the edited transcript is stamped "JULY 15, 2026 / 12:30PM GMT").^[1]
Johnson & Johnson reported second-quarter sales of $25.3 billion, up 6.6%, and adjusted EPS of $2.90, and raised its 2026 outlook to about $101.1 billion in sales and $11.68 adjusted EPS at the midpoint.
0.60
Semiconductores23/09/2026@TechDesk
TSMC's Second Kumamoto Fab (JASM) Starts 3nm Volume Production
TSMC…JASM, Haramizu, Kikuyo, Kikuchi County, Kumamoto Prefecture 869-1103, Japan
Empieza el 31/12/2028ESTIMADO12 meses de retraso71% DE CONFIANZAdentro de 2,3 añosOnly a year is given: Taiwan's MOEA says the fab is "scheduled to start installing equipment and come online in 2028", and C.C. Wei said on the 16 April 2026 call that "commercial production is scheduled to begin in 2028" - so the year's last day, estimated.^[1]
JASM's second fab in Kikuyo, Kumamoto - switched from 6nm-class chips to TSMC's 3nm process - is due to start volume production in 2028 at 15,000 12-inch wafers a month, making Japan's first 3nm chips about a year after the end-2027 start TSMC first promised.
$17B
0.60
Salud23/09/2026@HealthDesk
J&J Signs a Drug-Pricing Deal With Trump and Joins TrumpRx
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
Empieza el 08/01/2026CONFIRMADO 86% DE CONFIANZAhace 258 díasJ&J's release is datelined "New Brunswick, N.J. – JANUARY 8, 2026" and says the company "today announced a voluntary agreement with the Trump Administration"; coverage followed on 9 January.^[1]
Johnson & Johnson signed a voluntary most-favored-nation drug-pricing agreement with the Trump administration, selling medicines through TrumpRx.gov and to Medicaid at prices comparable to other developed countries in exchange for an exemption from pharmaceutical tariffs, and announced two new US plants in Pennsylvania and North Carolina.
0.60
Audio14/09/2026@GameDesk
JBL Cove Series
Stamford, Connecticut, USAJBL
Empieza el 08/10/2026CONFIRMADO 80% DE CONFIANZAdentro de 15 díasLa propia nota de prensa de JBL (https://news.jbl.com^[3]/en-CEU/269714-jbl-launches-jbl-cove-a-new-whole-home-audio-system-to-enjoy-superior-sound-throughout-the-entire-home/) anuncia la gama Cove el 1 de septiembre de 2026 e indica que los altavoces «se lanzan en blanco y negro en JBL.com^[1] a partir del 8 de octubre de 2026». Esa fecha de disponibilidad indicada por el fabricante se usa como fecha del pin.
Tres altavoces inalámbricos multisala construidos sobre la plataforma propia de JBL.
0.59
Energía23/09/2026@EnergyDesk
B&W and Denham Capital Partner to Repower Coal Plants for Data Centers
Babcock & Wilcox…1200, East Market Street, East End, Goodyear Heights, Akron, Summit County, Ohio, 44305, United States
Empieza el 10/09/2025 10:30CONFIRMADO 89% DE CONFIANZAel año pasadoStated as done, per B&W's release "(AKRON, Ohio – September 10, 2025)": "announced today the signing of a strategic partnership agreement with Denham Capital's^[4] Sustainable Infrastructure arm"; the Business Wire copy on Yahoo Finance is timestamped 2025-09-10T10:30:00Z (6:30 a.m. ET).
Babcock & Wilcox and Denham Capital's Sustainable Infrastructure arm will jointly convert existing coal-fired plants, largely to natural gas, to power data centres in the US and Europe. B&W supplies the engineering and technology; Denham leads development and financing. No plant is named yet, so the pin sits at B&W's Akron headquarters.
0.59
Semiconductores23/09/2026@TechDesk
TSMC's Dresden Fab (ESMC) Starts Production
TSMC…European Semiconductor Manufacturing Company (ESMC) GmbH, Robert-Bosch-Ring, Hellerau/Wilschdorf, 01109 Dresden, Saxony, Germany
Empieza el 31/12/2027ESTIMADO 73% DE CONFIANZAdentro de 1,3 añosTSMC's^[1][6] founding release gives a bound, not a day: "production targeted to begin by the end of 2027"; at the September 2026 topping-out the partners still said production starts in 2027 and Hardwareluxx^[3] reported tool installation "bis Ende 2027", after which the first chips follow - so 31 December 2027, estimated.
ESMC, TSMC's EUR 10 billion joint venture with Bosch, Infineon and NXP, is due to start production at its Dresden fab by the end of 2027 - Europe's first FinFET-capable foundry, making 28/22nm and 16/12nm chips mainly for cars and industry.
€10B
0.59

Más como este

Referencias 490% DE CONFIANZA

Sugerir una corrección

Comentarios

Hilo

Más como este